Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, April 2006, p. 1347-1351, Vol. 50, No. 4
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.4.1347-1351.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa
Didier Hocquet,1*
Patrice Nordmann,2
Farid El Garch,1
Ludovic Cabanne,2 and
Patrick Plésiat1
Laboratoire de Bactériologie, Hôpital Jean Minjoz, University of Franche-Comte, Besançon, France,1
Service de Bactériologie-Virologie, Hopital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Univesité Paris XI, K-Bicêtre, France2
Received 12 August 2005/
Returned for modification 2 October 2005/
Accepted 29 January 2006
Cefepime (FEP) and ceftazidime (CAZ) are potent ß-lactam antibiotics with similar MICs (1 to 2 µg/ml) for wild-type strains of Pseudomonas aeruginosa. However, recent epidemiological studies have highlighted the occurrence of isolates more resistant to FEP than to CAZ (FEPr/CAZs profile). We thus investigated the mechanisms conferring such a phenotype in 38 clonally unrelated strains collected in two French teaching hospitals. Most of the bacteria (n = 32; 84%) appeared to stably overexpress the mexY gene, which codes for the RND transporter of the multidrug efflux system MexXY-OprM. MexXY up-regulation was the sole FEP resistance mechanism identified (n = 12) or was associated with increased levels of pump MexAB-OprM (n = 5) or MexJK (n = 2), synthesis of secondary ß-lactamase PSE-1 (n = 10), derepression of cephalosporinase AmpC (n = 1), coexpression of both OXA-35 and MexJK (n = 1), or production of both PSE-1 and MexAB-OprM (n = 1). Down-regulation of the mexXY operon in seven selected strains by the plasmid-borne repressor gene mexZ decreased FEP resistance from two- to eightfold, thereby demonstrating the significant contribution of MexXY-OprM to the FEPr/CAZs phenotype. The six isolates of this series that exhibited wild-type levels of the mexY gene were found to produce ß-lactamase PSE-1 (n = 1), OXA-35 (n = 4), or both PSE-1 and OXA-35 (n = 1). Altogether, these data provide evidence that MexXY-OprM plays a major role in the development of FEP resistance among clinical strains of P. aeruginosa.
* Corresponding author. Mailing address: Laboratoire de Bactériologie, Hôpital Jean Minjoz, 25030 Besançon cedex, France. Phone: 33 3 81 66 82 86. Fax: 33 3 81 66 89 14. E-mail:
dhocquet{at}chu-besancon.fr.
Antimicrobial Agents and Chemotherapy, April 2006, p. 1347-1351, Vol. 50, No. 4
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.4.1347-1351.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Rodriguez-Martinez, J.-M., Poirel, L., Nordmann, P.
(2009). Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
53: 4783-4788
[Abstract]
[Full Text]
-
Lister, P. D., Wolter, D. J., Hanson, N. D.
(2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev.
22: 582-610
[Abstract]
[Full Text]
-
Yamamoto, M., Ueda, A., Kudo, M., Matsuo, Y., Fukushima, J., Nakae, T., Kaneko, T., Ishigatsubo, Y.
(2009). Role of MexZ and PA5471 in transcriptional regulation of mexXY in Pseudomonas aeruginosa. Microbiology
155: 3312-3321
[Abstract]
[Full Text]
-
Wolter, D. J., Black, J. A., Lister, P. D., Hanson, N. D.
(2009). Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype. J Antimicrob Chemother
64: 294-300
[Abstract]
[Full Text]
-
Pena, C., Suarez, C., Tubau, F., Juan, C., Moya, B., Dominguez, M. A., Oliver, A., Pujol, M., Ariza, J.
(2009). Nosocomial Outbreak of a Non-Cefepime-Susceptible Ceftazidime-Susceptible Pseudomonas aeruginosa Strain Overexpressing MexXY-OprM and Producing an Integron-Borne PSE-1 ss-Lactamase. J. Clin. Microbiol.
47: 2381-2387
[Abstract]
[Full Text]
-
Baum, E. Z., Crespo-Carbone, S. M., Morrow, B. J., Davies, T. A., Foleno, B. D., He, W., Queenan, A. M., Bush, K.
(2009). Effect of MexXY Overexpression on Ceftobiprole Susceptibility in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
53: 2785-2790
[Abstract]
[Full Text]
-
Vettoretti, L., Plesiat, P., Muller, C., El Garch, F., Phan, G., Attree, I., Ducruix, A., Llanes, C.
(2009). Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients. Antimicrob. Agents Chemother.
53: 1987-1997
[Abstract]
[Full Text]
-
Rodriguez-Martinez, J.-M., Poirel, L., Nordmann, P.
(2009). Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
53: 1766-1771
[Abstract]
[Full Text]
-
Jeannot, K., Elsen, S., Kohler, T., Attree, I., van Delden, C., Plesiat, P.
(2008). Resistance and Virulence of Pseudomonas aeruginosa Clinical Strains Overproducing the MexCD-OprJ Efflux Pump. Antimicrob. Agents Chemother.
52: 2455-2462
[Abstract]
[Full Text]
-
Hocquet, D., Muller, A., Blanc, K., Plesiat, P., Talon, D., Monnet, D. L., Bertrand, X.
(2008). Relationship between Antibiotic Use and Incidence of MexXY-OprM Overproducers among Clinical Isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
52: 1173-1175
[Abstract]
[Full Text]
-
Gutierrez, O., Juan, C., Cercenado, E., Navarro, F., Bouza, E., Coll, P., Perez, J. L., Oliver, A.
(2007). Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals. Antimicrob. Agents Chemother.
51: 4329-4335
[Abstract]
[Full Text]
-
Henrichfreise, B., Wiegand, I., Pfister, W., Wiedemann, B.
(2007). Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with Hypermutation. Antimicrob. Agents Chemother.
51: 4062-4070
[Abstract]
[Full Text]
-
Hocquet, D., Berthelot, P., Roussel-Delvallez, M., Favre, R., Jeannot, K., Bajolet, O., Marty, N., Grattard, F., Mariani-Kurkdjian, P., Bingen, E., Husson, M.-O., Couetdic, G., Plesiat, P.
(2007). Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections. Antimicrob. Agents Chemother.
51: 3531-3536
[Abstract]
[Full Text]
-
Plasencia, V., Borrell, N., Macia, M. D., Moya, B., Perez, J. L., Oliver, A.
(2007). Influence of High Mutation Rates on the Mechanisms and Dynamics of In Vitro and In Vivo Resistance Development to Single or Combined Antipseudomonal Agents. Antimicrob. Agents Chemother.
51: 2574-2581
[Abstract]
[Full Text]
-
Cavallo, J. D., Hocquet, D., Plesiat, P., Fabre, R., Roussel-Delvallez, M., on behalf of GERPA,
(2007). Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study. J Antimicrob Chemother
59: 1021-1024
[Abstract]
[Full Text]
-
Hocquet, D., Roussel-Delvallez, M., Cavallo, J.-D., Plesiat, P.
(2007). MexAB-OprM- and MexXY-Overproducing Mutants Are Very Prevalent among Clinical Strains of Pseudomonas aeruginosa with Reduced Susceptibility to Ticarcillin. Antimicrob. Agents Chemother.
51: 1582-1583
[Full Text]
-
Reinhardt, A., Kohler, T., Wood, P., Rohner, P., Dumas, J.-L., Ricou, B., van Delden, C.
(2007). Development and Persistence of Antimicrobial Resistance in Pseudomonas aeruginosa: a Longitudinal Observation in Mechanically Ventilated Patients. Antimicrob. Agents Chemother.
51: 1341-1350
[Abstract]
[Full Text]
-
Mesaros, N., Glupczynski, Y., Avrain, L., Caceres, N. E., Tulkens, P. M., Van Bambeke, F.
(2007). A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa. J Antimicrob Chemother
59: 378-386
[Abstract]
[Full Text]
-
El'Garch, F., Jeannot, K., Hocquet, D., Llanes-Barakat, C., Plesiat, P.
(2007). Cumulative Effects of Several Nonenzymatic Mechanisms on the Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimicrob. Agents Chemother.
51: 1016-1021
[Abstract]
[Full Text]